Article Information
History
- December 6, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Maylis Layan1,2,3,4,*,
- David R M Smith5,
- Solen Kernéis6,7,
- Loïc Simon8,
- Catherine Dumartin9,10,
- Lory Dugravot8,
- Amélie Jouzeau8,
- Sylvie Maugat11,
- Laetitia Gambotti11,
- Laurence Watier2,4,
- Lulla Opatowski2,4,‡ and
- Laura Temime1,3,‡
- 1PACRI unit, Institut Pasteur, Conservatoire national des arts et métiers, Paris, France
- 2Epidemiology and Modelling of Antibiotic Evasion (EMAE), Institut Pasteur, Université de Paris, Paris, France
- 3Modélisation, épidémiologie et surveillance des risques sanitaires (MESuRS), Conservatoire national des arts et métiers, Paris, France
- 4CESP, Anti-infective evasion and pharmacoepidemiology team, Université Paris-Saclay, UVSQ, Inserm, Montigny-Le- Bretonneux, France
- 5Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK
- 6Université Paris Cité, INSERM, IAME, F-75018 Paris, France
- 7Equipe de Prévention du Risque Infectieux (EPRI), AP-HP, Hôpital Bichat, Paris, France
- 8CPIAS Grand-Est, CHRU Nancy, France
- 9CPIAS Nouvelle-Aquitaine, CHU de Bordeaux, Bordeaux, France
- 10Univ. Bordeaux, INSERM, BPH, U1219, Team AHeaD, Bordeaux, France
- 11French National Public Health Agency, Department of Infectious Diseases, Saint-Maurice, France
- ↵*Corresponding author:Maylis Layan (m.layan{at}hotmail.fr)
↵‡ Contributed equally
Posted December 06, 2024.
Impacts of the COVID-19 pandemic on antibiotic use and resistance in hospitals: a retrospective ecological analysis of French national surveillance data over 2019-2022
